{"id":30825,"date":"2025-10-06T15:27:45","date_gmt":"2025-10-06T14:27:45","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=30825"},"modified":"2025-10-13T08:05:49","modified_gmt":"2025-10-13T07:05:49","slug":"rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/","title":{"rendered":"Rapports de l&#8217;OMS sur le d\u00e9veloppement de nouveaux tests et traitements pour les infections bact\u00e9riennes"},"content":{"rendered":"\n<p>L&#8217;Organisation mondiale de la sant\u00e9 (OMS) publie ses derniers rapports sur les agents antibact\u00e9riens en cours de d\u00e9veloppement clinique et pr\u00e9clinique, ainsi que sur les diagnostics d\u00e9j\u00e0 disponibles ou en cours d&#8217;\u00e9laboration pour d\u00e9tecter et identifier les bact\u00e9ries prioritaires figurant sur la liste des pathog\u00e8nes bact\u00e9riens prioritaires. Ces deux rapports visent \u00e0 orienter la recherche et le d\u00e9veloppement dans le domaine des antibact\u00e9riens afin de lutter plus efficacement contre la menace croissante de la r\u00e9sistance aux antimicrobiens.<\/p>\n\n\n\n<div class=\"wp-block-buttons has-custom-font-size has-small-font-size is-content-justification-left is-layout-flex wp-container-core-buttons-is-layout-1 wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button has-custom-font-size is-style-outline has-small-font-size\"><a class=\"wp-block-button__link has-luminous-vivid-orange-color has-text-color has-link-color wp-element-button\" href=\"https:\/\/www.who.int\/news\/item\/02-10-2025-who-releases-new-reports-on-new-tests-and-treatments-in-development-for-bacterial-infections\" target=\"_blank\" rel=\"noreferrer noopener\">En savoir plus<\/a><\/div>\n<\/div>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-media-text is-stacked-on-mobile\" style=\"grid-template-columns:24% auto\"><figure class=\"wp-block-media-text__media\"><img decoding=\"async\" width=\"170\" height=\"240\" src=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/analysis-of-antibacterial.png\" alt=\"\" class=\"wp-image-30817 size-full\"\/><\/figure><div class=\"wp-block-media-text__content\">\n<p>Analyse des agents antibact\u00e9riens en d\u00e9veloppement clinique et pr\u00e9clinique : aper\u00e7u et analyse 2025<\/p>\n\n\n\n<div class=\"wp-block-buttons has-custom-font-size has-small-font-size is-content-justification-left is-layout-flex wp-container-core-buttons-is-layout-2 wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button has-custom-font-size is-style-outline has-small-font-size\"><a class=\"wp-block-button__link has-luminous-vivid-orange-color has-text-color has-link-color wp-element-button\" href=\"https:\/\/iris.who.int\/items\/bf7dbc91-95e5-4bc8-a2d6-2f0dac582a88\" target=\"_blank\" rel=\"noreferrer noopener\">Lire le rapport<\/a><\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-media-text is-stacked-on-mobile\" style=\"grid-template-columns:24% auto\"><figure class=\"wp-block-media-text__media\"><img decoding=\"async\" width=\"170\" height=\"240\" src=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/landscape-analysis-of-commercially.png\" alt=\"\" class=\"wp-image-30819 size-full\"\/><\/figure><div class=\"wp-block-media-text__content\">\n<p>Analyse comparative des diagnostics in vitro disponibles dans le commerce et en cours de d\u00e9veloppement pour les bact\u00e9ries pathog\u00e8nes prioritaires<\/p>\n\n\n\n<div class=\"wp-block-buttons has-custom-font-size has-small-font-size is-content-justification-left is-layout-flex wp-container-core-buttons-is-layout-3 wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button has-custom-font-size is-style-outline has-small-font-size\"><a class=\"wp-block-button__link has-luminous-vivid-orange-color has-text-color has-link-color wp-element-button\" href=\"https:\/\/www.who.int\/publications\/i\/item\/9789240109827\" target=\"_blank\" rel=\"noreferrer noopener\">Lire le rapport<\/a><\/div>\n<\/div>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>L&#8217;Organisation mondiale de la sant\u00e9 (OMS) publie ses derniers rapports sur les agents antibact\u00e9riens en cours de d\u00e9veloppement clinique et pr\u00e9clinique, ainsi que sur les diagnostics d\u00e9j\u00e0 disponibles ou en cours d&#8217;\u00e9laboration pour d\u00e9tecter et identifier les bact\u00e9ries prioritaires figurant sur la liste des pathog\u00e8nes bact\u00e9riens prioritaires. Ces deux rapports visent \u00e0 orienter la recherche [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31,37,26],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Rapports de l&#039;OMS sur le d\u00e9veloppement de nouveaux tests et traitements pour les infections bact\u00e9riennes - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rapports de l&#039;OMS sur le d\u00e9veloppement de nouveaux tests et traitements pour les infections bact\u00e9riennes - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-06T14:27:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-13T07:05:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/analysis-of-antibacterial.png\" \/>\n<meta name=\"author\" content=\"Emmanuel Auchet\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emmanuel Auchet\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/\"},\"author\":{\"name\":\"Emmanuel Auchet\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8\"},\"headline\":\"Rapports de l&#8217;OMS sur le d\u00e9veloppement de nouveaux tests et traitements pour les infections bact\u00e9riennes\",\"datePublished\":\"2025-10-06T14:27:45+00:00\",\"dateModified\":\"2025-10-13T07:05:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/\"},\"wordCount\":153,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/analysis-of-antibacterial.png\",\"articleSection\":[\"Actualit\u00e9s\",\"Bilans, rapports et recommandations\",\"Infos pratiques &amp; communications\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/\",\"name\":\"Rapports de l'OMS sur le d\u00e9veloppement de nouveaux tests et traitements pour les infections bact\u00e9riennes - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/analysis-of-antibacterial.png\",\"datePublished\":\"2025-10-06T14:27:45+00:00\",\"dateModified\":\"2025-10-13T07:05:49+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/analysis-of-antibacterial.png\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/analysis-of-antibacterial.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Rapports de l\u2019OMS sur le d\u00e9veloppement de nouveaux tests et traitements pour les infections bact\u00e9riennes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8\",\"name\":\"Emmanuel Auchet\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rapports de l'OMS sur le d\u00e9veloppement de nouveaux tests et traitements pour les infections bact\u00e9riennes - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/","og_locale":"fr_FR","og_type":"article","og_title":"Rapports de l'OMS sur le d\u00e9veloppement de nouveaux tests et traitements pour les infections bact\u00e9riennes - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2025-10-06T14:27:45+00:00","article_modified_time":"2025-10-13T07:05:49+00:00","og_image":[{"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/analysis-of-antibacterial.png"}],"author":"Emmanuel Auchet","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Emmanuel Auchet","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/"},"author":{"name":"Emmanuel Auchet","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8"},"headline":"Rapports de l&#8217;OMS sur le d\u00e9veloppement de nouveaux tests et traitements pour les infections bact\u00e9riennes","datePublished":"2025-10-06T14:27:45+00:00","dateModified":"2025-10-13T07:05:49+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/"},"wordCount":153,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/analysis-of-antibacterial.png","articleSection":["Actualit\u00e9s","Bilans, rapports et recommandations","Infos pratiques &amp; communications"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/","name":"Rapports de l'OMS sur le d\u00e9veloppement de nouveaux tests et traitements pour les infections bact\u00e9riennes - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/analysis-of-antibacterial.png","datePublished":"2025-10-06T14:27:45+00:00","dateModified":"2025-10-13T07:05:49+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/analysis-of-antibacterial.png","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/10\/analysis-of-antibacterial.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/rapports-de-loms-sur-le-developpement-de-nouveaux-tests-et-traitements-pour-les-infections-bacteriennes-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/"},{"@type":"ListItem","position":4,"name":"Rapports de l\u2019OMS sur le d\u00e9veloppement de nouveaux tests et traitements pour les infections bact\u00e9riennes"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8","name":"Emmanuel Auchet"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-10 21:02:28","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/30825"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=30825"}],"version-history":[{"count":4,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/30825\/revisions"}],"predecessor-version":[{"id":30843,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/30825\/revisions\/30843"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=30825"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=30825"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=30825"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}